Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer.

However, the different incidences of neuropathy with the two regimens did not reach statistical significance when results were adjusted for preexisting neuropathy and number of prior chemotherapies [ 58 ].

also in 111,027 other papers